(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.
J Med Chem
; 51(9): 2722-33, 2008 May 08.
Article
in En
| MEDLINE
| ID: mdl-18412317
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Triazoles
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Hydroxymethylglutaryl CoA Reductases
Type of study:
Etiology_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2008
Type:
Article
Affiliation country:
United States